Decoy Therapeutics, Inc. (DCOY)
0.758
+0.04
(+6.31%)
USD |
NASDAQ |
Jan 22, 16:00
0.7505
-0.01
(-0.99%)
After-Hours: 16:52
Decoy Therapeutics Free Cash Flow: -4.433M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 6.436B |
| Amgen, Inc. | 11.54B |
| CorMedix, Inc. | 74.42M |
| Vor Biopharma, Inc. | -144.67M |
| Humacyte, Inc. | -106.40M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.647M |
| Cash from Investing (Quarterly) | -0.20M |
| Cash from Financing (Quarterly) | 5.862M |
| Free Cash Flow Per Share (Quarterly) | -3.419 |
| Free Cash Flow to Equity (Quarterly) | -1.647M |
| Free Cash Flow to Firm (Quarterly) | -1.647M |
| Free Cash Flow Yield | -981.7% |